Form 4 for HCAT Health Catalyst, Inc.
Accepted 2024-03-05 00:00:00 ET · period of report 2024-03-01 · accession 0001562180-24-002256 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-05 | 2024-03-01 | HCAT | Alger Jason | CFO | F - Tax | $8.05 | -2,474 | 52.2K | -5% | -$19.9K | |
| 2024-03-05 | 2024-03-01 | HCAT | Alger Jason | CFO | A - Grant | $0.00 | +70.0K | 122.2K | +134% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-01 | F | D | 2,474 | $8.05 | 52,231 | D | — | — | |
| 2 | Common | Common Stock | 2024-03-01 | A | A | 70,000 | $0.00 | 122,231 | D | — | — | (F2) Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, 33.33% of the RSUs will vest on December 1, 2024 and, thereafter, the remaining 66.67% of the RSUs will vest in 8 equal quarterly installments. |